Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Jeger RV, Eccleshall S, Wan Ahmad WA, et al. Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group. Cardiovasc Interv. 2020;13(12):1391–402.
2. Neumann F-J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
3. Jeger RV, Farah A, Ohlow M-A, et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet. 2018;392(10150):849–56.
4. Jeger RV, Farah A, Ohlow M-A, et al. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet. 2020;396(10261):1504–10.
5. Sanz Sánchez J, Chiarito M, Cortese B, et al. Drug-coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: a meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2021;98(1):66–75.